Belle, the largest in-home foot care company in the U.S., and Cloud303, a leading provider of cloud-based healthcare solutions, today announced the two organizations will accelerate the development of ...

Once-weekly efsitora is noninferior to once-daily degludec for reducing glycated hemoglobin levels in adults with type 2 diabetes who have not received insulin.

Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal ...

Cardiovascular events are not significantly decreased with edetate disodium chelation in patients with CAD and history of myocardial infarction and diabetes.

Diabetes affects 37 million people in the U.S. The Centers for Disease Control and Prevention estimates another 96 million people – or 1 in 3 adults – have prediabetes, a condition where blood sugar ...

The walk will happen at Old Grove Park in West Haven on Saturday, Sept. 28. White House Cabinet officials rally around Biden ...

Robert Papalia, 74, retired early to care for his ailing wife, Marie, and they're struggling financially given high medical ...

Plus, the Valley Baptist Legacy Foundation has awarded $30 million for a center to treat people with diabetes in Texas’s Rio ...

U.S. Sen. Bernie Sanders said major PBMs have agreed not to limit coverage of Ozempic and Wegovy if Novo lowers its prices.

DexCom ( DXCM -1.08%) is not a stock that investors should be rushing to sell. It has a few different opportunities to ...

Novo Nordisk's top executive faced a Senate grilling on Tuesday over the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both injections soars in the ...

GLP-1 agonists, widely used for obesity and diabetes management, have been associated with a reduced risk of most ...